ARK 每周股评 – 1/15/2022

我们每周都会与投资者分享我们策略中一周内一天内升值或下跌超过15%的股票的周评。我们希望您觉得这篇评论有用。

We share weekly commentaries with investors on stocks in our strategies that have appreciated or dropped more than 15% in a day during the course of the week. We hope you find this commentary useful.

CareDx (CDNA)

+18%

CareDx (CDNA), an industry leader in supporting transplant procedures and monitoring/aiding outcomes, traded up 18% on Monday after preannouncing much stronger than expected financial results for the fourth quarter and better than expected guidance for 2022. 注: CareDx (CDNA)是支持移植手术和监测/帮助结果的行业领导者，在预宣布第四季度的财务业绩远高于预期和2022年的指导意见后，周一交易上涨18%。

Accolade (ACCD)

+25%	Accolade (ACCD), a leading company in healthcare benefits management, traded up over 25% on Tuesday after announcing positive financial results for its fiscal third quarter as it continues along a path to profitability. 注: 医疗保健福利管理的领先公司Accolade（ACCD）在宣布第三财季积极的财务业绩后，周二交易价格上涨超过25%，该公司继续沿着盈利的道路前进。

Butterfly Network (BFLY)

+19%	Butterfly Network (BFLY), a leader in the medical imaging field, traded up 19% on Tuesday after announcing that the Rochester Medical Group will deploy Butterfly’s technology throughout its enterprise. 注: 医学成像领域的领导者Butterfly Network（BFLY）在宣布罗切斯特医疗集团将在整个企业中部署Butterfly的技术后，周二交易量上升了19%。

Nurix Therapeutics (NRIX)

-15%	Nurix Therapeutics (NRIX), a leading company in the emerging targeted protein therapeutics (TPD) space, traded down 15% on Tuesday after announcing a slight delay in the release of clinical data. 注: Nurix Therapeutics（NRIX）是新兴的靶向蛋白疗法（TPD）领域的一家领先公司，在宣布略微推迟发布临床数据后，周二交易价格下跌了15%。